Abstract
INTRODUCTION:A 71-year-old patient with a diagnosis of atrial fibrillation and recurrent strokes, treated with various anticoagulants, the stroke treatment in Colombia for 2008 was $ 450 billion Colombian pesos.
OBJECTIVE:To estimate the hospital cost of caring for a patient with recurrent stroke secondary to atrial fibrillation.
METHODS:Partial economic study of micro costing of in-hospital care for a case of recurrent severe spectrum stroke, which does not necessarily reflect the average case. Resource consumption was valued using national reference rates. The results are presented in current 2019 prices (Colombian pesos and US dollars).
RESULTS:Patient with 3 hospital events, who was hospitalized for 31 days. Hospitalizations had costs of $ 53,883,490 (USD 16,141.1), $ 6,343,096 (USD 1,900.1) and $ 15,719,443 (USD 4,708.9) respectively, with an average price for each hospitalization of $ 25,315,343 (USD 7,583.4), total cost of $ 75,946,029 (USD 22,750.1) daily cost of $ 2,449,872 (USD 729.5). The item that consistently increased costs was procedures (35.7 %).
CONCLUSIONS:Recurrent stroke caused by nonvalvular atrial fibrillation is associated with a significant increase in direct costs, with an impact of almost twice the GDP per capita. A timely diagnosis and proper selection can reduce it.
References
Saver JL. Cryptogenic Stroke. N Engl J Med. 2016;374(21):2065-74.
Palacios Sánchez E, Darío Triana J, María Gómez A, Ibarra Quiñones M. Ataque cerebrovascular isquémico caracterización demográfica y clínica. Repert Med Cir. 2014;23(2):127-33.
van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med. 2007;357(6):572-9.
Adams HP, Bendixen BH, Kappelle J, Biller J, Love BB, David L, et al. Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke. 1993;24(1):35-41.
Rodriguez P, Valero L, Pi S, Sanchez A, Lizan L. Uso de nuevos anticoagulantes orales (NACO) en la prevención del ictus y la embolia sistémica en pacientes con fibrilación auricular no valvular (FANV). Agora Salut. 2018;5(45):411-20.
Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, et al. Anticoagulation after stroke in patients with atrial fibrillation. Stroke. 2019; 50(8):2093-100.
Wicke FS, Schaller MA, Karymova K, Beyer M, Müller BS. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany. BMC Cardiovasc Disord. 2019;19(94):1-8.
Urmeneta LL. Fibrilación auricular y anticoagulación oral. Universidad Pública de Navarra; 2014.
Buitrago AF, Gómez M, Soto M, Díaz JH. Nuevos anticoagulantes orales en fibrilación auricular no valvular. Rev Colomb Cardiol. 2012;19(4):184-91.
Saxena R, Lewis S, Berge E, Sandercock PAG, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32(10):2333-7.
Best JG, Bell R, Haque M, Chandratheva A, Werring DJ. Atrial fibrillation and stroke: A practical guide. Pract Neurol. 2019;19(3):208-24.
MacGrory B, Flood S, Schrag M, Paciaroni M, Yaghi S. Anticoagulation resumption after stroke from atrial fibrillation. Curr Atheroscler Rep. 2019;21(29):1-11.
Paciaroni M, Agnelli G, Ageno W, Caso V. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation. Thromb Haemost. 2016;116(3):410-6.
Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marche-selli S, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: Effect of anticoagulation and its timing: The RAF study. Stroke. 2015;46(8):2175-82.
Masjuan J, Salido L, DeFelipe A, Hernández-Antolín R, Fernández-Golfín C, Cruz-Culebras A, et al. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardio-embolic stroke. Eur J Neurol. 2019;26(5):816-20.
Mendoza-Sánchez JA, Silva FA, Rangel-Celis LM, Arias JE, Zuñiga-Sierra EA. Model of costs associated with stroke and adverse events in patients with non-valvular atrial fibrillation treated with warfarin. Rev Colomb Cardiol. 2019;26(3):125-32.
Chirveches M. Estimación de la carga de Enfermedad cerebro-vascular para Colombia en el año 2014 [Internet] [citado Abr. 18 2019]. Disponible en: Disponible en: http://bibliotecavirtualoducal.uc.cl:8081/handle/10554/18934
Castañeda-Cardona C, Coral-Casas J, Rueda C, Diaz C, Rueda M, Rosselli D. Análisis de costos de atención de infarto cerebral agudo con o sin fibrilación auricular. Acta Neurológica Colomb. 2014;30(2):78-82.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467-77.
Tu HT, Campbell BC, Christensen S, Desmond PM, De Silva DA, Parsons MW , et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke. 2015;10(4):534-40.
Hayden DT, Hannon N, Callaly E, Ní Chróinín D, Horgan G, Kyne L, et al. Rates and determinants of 5-year outcomes after atrial fibrillation-related stroke: A population study. Stroke. 2015;46(12):3488-93.
Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified rankin scale: A systematic review. Stroke. 2009;40(10):3393-5.
Forero T, Ocampo J. Manual tarifario de salud SOAT 2019 [Internet]. 2019 [citado 18 Mayo 2020]. p. 1-112. Disponible en: Disponible en: https://consultorsalud.com/wp-content/uploads/2019/01/manual_tarifario_soat_de_salud_2019_-_consultorsalud_1.pdf
SISMED. Consulta pública de precios de medicamentos en la cadena de comercialización [Internet]. 2012 [citado 18 Mayo 2020]. Disponible en: Disponible en: https://web.sispro.gov.co/WebPublico/Consultas/ConsultarCNPMCadenaComercializacionCir-cu2yPA_028_2_2.aspx
Comportamiento del mercado del dólar durante el día (información en tiempo real) | Banco de la República (banco central de Colombia) [Internet] [citado 6 Jul. 2021]. Disponible en: https://www.banrep.gov.co/es/estadisticas/comportamiento-del-mercado-del-dolar-durante-el-dia-informacion-tiempo-real
Manual para la elaboración de evaluaciones económicas en salud [Internet] [citado Jul. 6 2021]. Disponible en: http://www.iets.org.co/Archivos/64/Manual_evaluacion_economica.pdf
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11-21.
Hannon N, Daly L, Murphy S, Smith S, Hayden D, Chróinín DN, et al. Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: Population-based study. Stroke. 2014;45(12):3670-4.
Mukherjee K, Kamal KM. Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA. IntJ Stroke. 2019;14(2):159-66.
Pan X, Simon TA, Hamilton M, Kuznik A. Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States. J Thromb Thrombolysis. 2015;39(4):508-15.
Huang Y, Liao X, Song Z, Wang L, Xiao M, Zhong S. Evaluation of the influence of etiological factor on the economic burden of ischemic stroke in younger patients in China using the trial of org 10172 in acute stroke treatment (TOAST) classification. Med Sci Monit. 2019;25:637-42.
Kochanek KD, Murphy S, Xu J, Arias E. Mortality in the United States, 2016. NCHS data brief. 2017.
Chang KC, Tseng MC. Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke. 2003;34(11):e219-21.
Alvarez-Sabín J, Quintana M, Masjuan J, Oliva-Moreno J, Mar J, Gonzalez-Rojas N, et al. Economic impact of patients admitted to stroke units in Spain. Eur J Heal Econ. 2017;18(4):449-58.
Cotté FE, Chaize G, Kachaner I, Gaudin AF, Vainchtock A, Durand-Zaleski I. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France. J Stroke Cerebrovasc Dis. 2014;23(2):e73-83.
Wen L, Wu J, Feng L, Yang L, Qian F. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China. Curr Med Res Opin. 2017;33(10):1789-94.
Santamarina E, Alvarez Sabín J. Impacto social del ictus producido por fibrilación auricular. Neurología. 2012;27(Supl. 1):10-4.
Kanavos P, Parkin GC, Kamphuis B, Gill J. Latin America healthcare system overview. A comparative analysis of fiscal space in healthcare. London School of Economics and Political Science; 2019.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.